Knud Fabrin
Papers
1
Total Citations
5
H-Index
1
About
Knud Fabrin is a leading urologic surgeon whose research focuses on improving surgical outcomes for patients undergoing radical cystectomy for bladder cancer. His work centers on refining operative techniques to reduce debilitating postoperative complications, particularly benign ureteroenteric strictures, which affect roughly 15% of patients. Fabrin’s most significant contribution is his leadership of the MOSAIC randomized controlled trial (DaBlaCa-16), which investigates the retrosigmoid versus conventional ileal conduit in robot-assisted radical cystectomy. This pioneering study addresses a critical clinical challenge: the high rate of left-sided strictures. By demonstrating the feasibility of the retrosigmoid approach, his work offers a potential paradigm shift to lower stricture rates and improve patient quality of life. With his most-cited paper from 2024 already garnering attention, Fabrin’s research is shaping the future of reconstructive urology. His dedication to rigorous, randomized evidence marks him as a key figure in advancing surgical standards and minimizing long-term morbidity for bladder cancer survivors.
Research Focus
Key Achievements
Top Papers
- 1